Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) announced today that it has entered into an amendment to its senior secured credit agreement, which, after giving effect to the amendment, consists of a $2.8 billion senior secured asset-based revolving credit facility and a $350 million “first-in, last out” senior secured term loan facility. The new facilities extend the Company's debt maturity profile and provides improved pricing on the “first-in, last out” senior secured term

Rite Aid Announces Successful Amendment and Extension to Credit Agreement

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) announced the availability of flu vaccines at all stores beginning today. Additionally, by expanding its COVID-19 online scheduling tool to include flu and ancillary vaccinations, Rite Aid now offers online scheduling in addition to walk-in availability for flu shots. Following CDC warnings that influenza infection rates could return to pre-pandemic levels this flu season, Rite Aid is making it as simple and convenient as possible to get the

Rite Aid Announces Availability of Flu Vaccines at All Locations

BIRMINGHAM, Ala., Aug. 5, 2021 /PRNewswire/ -- Same-day delivery service Shipt and Rite Aid (NYSE: RAD) today announced a partnership to bring same-day delivery of health and wellness products to Rite Aid's retail footprint across 17 states.

Shipt, Rite Aid Announce Same-Day Delivery Partnership

CHICAGO & CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid has selected dunnhumby, the global leader in customer data science, as its strategic partner to revamp its price, promotion and loyalty programs. Rite Aid and dunnhumby are utilizing customer data models and consumer-led insights to optimize these investments to improve customer value perception digitally and at more than 2,500 stores in 17 states. Rite Aid's loyalty program will be completely reimagined to deliver improved value for customers

Rite Aid Partners with dunnhumby to Revamp Price, Promotion and Loyalty Programs

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid will launch its 27th annual customer fundraising campaign supporting Children's Miracle Network Hospitals in August.

Rite Aid Rallies for Children's Miracle Network Hospitals

Shares of the drugstore chain gained on what looked like a short squeeze.

Why Rite Aid Stock Is Climbing This Week

Bio-Rad Laboratories

The stock price of Bio-Rad Laboratories, a life science research and clinical diagnostic products company, has seen a 10% rise over the last twenty-one trading days, while it is up 30% over the last year, driven by positive developments for the company. Last month, Bio-Rad announced its partnership.

What's Next For Bio-Rad Laboratories Stock After A 10% Rise In A Month?

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF), through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised[1], at-home COVID-19 PCR Test Kit. The co-branded kits, available at all Rite Aid stores across 17 states in the USA, will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients. The at-home COVID-19 nasal PCR kit is among the first over-the-counter at-home t

Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S.

Bear of the Day: Rite Aid (RAD)

BlackBerry

Manchester United

A diverse collection of companies are have their earnings reports next week, which should provide insights into the economic reopening. The post 3 Earnings Reports to Watch Next Week appeared first on InvestorPlace.

3 Earnings Reports to Watch Next Week

The retail sector was among the hardest hit by the COVID-19 pandemic, but one subsection emerged relatively unscathed: pharmacies. According to a report from foot traffic analytics firm Placer.ai, the pharmacy sector is now showing strong growth.

Placer.ai: Rite Aid could see ‘signficant' benefits from recent momentum

AbbVie

AmerisourceBergen

Cardinal Health

CVS Health

Endo International

Johnson & Johnson

McKesson

Teva Pharmaceutical

Walgreens

Walmart

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.

New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid

Rite Aid Corp. stock sank 5.7% in Friday trading after the stock was downgraded to underweight from neutral at JPMorgan. Analysts slashed their price target to $12 from $21.

Rite Aid stock slumps 18% for the week as weak outlook, diminished vaccine tailwind drive JPMorgan downgrade

Rite Aid's (RAD) Q1 results gain from accelerated vaccinations, the RxEvolution strategy and robust online growth.

Rite Aid's (RAD) Q1 Earnings Beat Estimates, Sales Miss

KB Home

As stock markets head for records, looking for disconnects between fundamentals and stock movements can be lucrative.

Strong Earnings, Falling Share Prices Make These 2 Stocks More Attractive

The company's latest guidance left much to be desired, to put it mildly.

Why Rite Aid Is Sinking This Week

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q1 2022 Results - Earnings Call Transcript

Rite Aid Corp (NYSE:RAD) shares plunged 13% Thursday morning after the company's most recent quarterly report. RAD reported earnings the beat expectations on Thursday morning, but revenues came short of estimates.

Should you buy Rite Aid after the earnings beat?

Shares of Rite Aid sank roughly 14% on Thursday, as Wall Street digested mixed quarterly results and weaker earnings guidance.

Rite Aid shares plummet; CEO cites Covid uncertainty for drug store chain's cautious outlook

Rite Aid Corp. (NYSE: RAD) said on Thursday its revenue in the fiscal first quarter came in weaker than expected, attributed to the pharmacy services business. Its Q1 profit, however, topped Wall Street estimates.

Rite Aid CEO plays defence on CNBC as stock falls 12%

Rite Aid, which has more than 2,500 retail pharmacy locations throughout 17 states, reported that revenues from continuing operations climbed by 2.2 percent to $6.16 billion. For the three months ending May 29, 2021, the retailer said that the rise in revenues was fueled by growth in its retail pharmacy segment that was offset, in part, […]

Rite Aid's Retail Pharmacy Business Drives Revenue Growth

The shares of Rite Aid Corporation (NYSE:RAD) are sitting out the broad market rally  today, last seen down 14.3% to trade at $17.48 after the pharmacy giant reported lackluster fiscal first-quarter results.

Options Traders Respond to Rite Aid's Revenue Miss

Rite Aid administered 4.7 million vaccines against Covid-19 in the company's first quarter, boosting sales.

Covid-19 Vaccines Boost Rite Aid Sales

Shares of Rite Aid (NYSE:RAD) moved higher by 2.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 1050.00% over the past year to $0.38, which beat the estimate of $0.22.

Recap: Rite Aid Q1 Earnings

Shares of Rite Aid Corp. sank 5.5% in premarket trading Thursday, after the drugstore chain beat fiscal first-quarter profit expectations but came up shy on revenue, amid weakness in the pharmacy services business, while also providing a mixed full-year outlook. The net loss for the quarter to May 29 narrowed to $13.1 million, or 24 cents a share, from $63.5 million, or $1.19 a share, in the year-ago period.

News for Rite Aid Stock (RAD)